Chloral Betaine

Summary

Chloral Betaine (CHEMBL3833335) is an approved small molecule.

At a glance

• Status: Approved (max clinical phase 4)
• Modality: Small molecule
• Chemistry: 282.5 Da · C7H14Cl3NO4

Identifiers

Drug identity and classification

Field	Value
ChEMBL ID	CHEMBL3833335
Name	Chloral Betaine
Type	Small molecule
Max phase	4
FDA approved	no
PubChem CID	16676
Molecular formula	C7H14Cl3NO4
Molecular weight	282.5
InChIKey	ONAOIDNSINNZOA-UHFFFAOYSA-N

SMILES: C[N+](C)(C)CC(=O)[O-].C(C(Cl)(Cl)Cl)(O)O

IUPAC name: 2,2,2-trichloroethane-1,1-diol;2-(trimethylazaniumyl)acetate

Also known as: Chloral betaine, Cloral betaina, Cloral betaine, CHLORAL BETAINE

Patent coverage: 585 distinct patent families (2,380 SureChEMBL compound mentions), from 1 matched compound structure(s). Mentions count patents naming the compound (not distinct inventions), so promiscuous / reference molecules inflate the mention figure — families are the dedup metric.

Targets

Targets

No target linkage available.

Bioactivity

No ChEMBL bioactivity rows at pChembl ≥ 5 (expected for biologics / antibodies).

Target pathways

No target-pathway data for this drug (no mapped target genes).

Indications & clinical

Indications

0 indication records carry no mapped disease name (EFO/MeSH-only); none shown.

Clinical trials

Total trials: 0.

Clinical evidence (CIViC)

No CIViC predictive evidence (expected for non-precision-medicine drugs).

Pharmacology

Pharmacogenomics

No PharmGKB pharmacogenomic data curated for this drug.

Related molecules

Related molecules

No competitor molecules sharing a primary target (ChEMBL phase ≥2 or PubChem drug-class).